Morgan Stanley Insmed Inc Transaction History

Morgan Stanley

$1.36 Trillion
Q1 2025

A detailed history of Morgan Stanley transactions in Insmed Inc stock. As of the latest transaction made, Morgan Stanley holds 1,059,656 shares of INSM stock, worth $77.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,059,656

Previous 1,351,365 21.59%

Holding current value

$77.1 Million

Previous $93.3 Million 13.35%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$65.25 - $83.83 $19 Million - $24.5 Million	-291,709 Reduced 21.59%	1,059,656 $80.8 Million
Q4 2024 Feb 14, 2025	BUY	$66.29 - $76.63 $2.01 Million - $2.33 Million	30,374 Added 2.3%	1,351,365 $93.3 Million
Q3 2024 May 14, 2025	BUY	$62.0 - $79.01 $30.9 Million - $39.4 Million	498,187 Added 60.55%	1,320,991 $96.4 Million
Q3 2024 Nov 14, 2024	BUY	$62.0 - $79.01 $30.9 Million - $39.4 Million	498,187 Added 60.55%	1,320,991 $96.4 Million
Q2 2024 May 14, 2025	SELL	$22.0 - $69.71 $11.6 Million - $36.8 Million	-528,561 Reduced 39.11%	822,804 $55.1 Million
Q2 2024 Oct 17, 2024	SELL	$22.0 - $69.71 $2.57 Million - $8.14 Million	-116,799 Reduced 12.43%	822,804 $55.1 Million
Q2 2024 Aug 14, 2024	SELL	$22.0 - $69.71 $2.57 Million - $8.14 Million	-116,799 Reduced 12.43%	822,804 $55.1 Million
Q1 2024 Oct 17, 2024	BUY	$25.72 - $29.94 $3 Million - $3.5 Million	116,799 Added 14.2%	939,603 $25.5 Million
Q1 2024 Aug 16, 2024	SELL	$25.72 - $29.94 $15.3 Million - $17.8 Million	-595,144 Reduced 38.78%	939,603 $25.5 Million
Q1 2024 May 15, 2024	SELL	$25.72 - $29.94 $15.3 Million - $17.8 Million	-595,144 Reduced 38.78%	939,603 $25.5 Million
Q4 2023 Aug 16, 2024	BUY	$23.42 - $31.74 $16.7 Million - $22.6 Million	711,943 Added 86.53%	1,534,747 $47.6 Million
Q4 2023 Feb 13, 2024	BUY	$23.42 - $31.74 $20 Million - $27.2 Million	856,021 Added 126.12%	1,534,747 $47.6 Million
Q3 2023 Nov 15, 2023	BUY	$19.86 - $26.93 $5.03 Million - $6.82 Million	253,242 Added 59.52%	678,726 $17.1 Million
Q2 2023 Aug 14, 2023	SELL	$16.44 - $21.1 $5.95 Million - $7.64 Million	-361,997 Reduced 45.97%	425,484 $8.98 Million
Q1 2023 May 15, 2023	SELL	$16.26 - $21.73 $3.08 Million - $4.12 Million	-189,459 Reduced 19.39%	787,481 $13.4 Million
Q4 2022 Feb 14, 2023	BUY	$16.98 - $23.15 $5.31 Million - $7.23 Million	312,505 Added 47.03%	976,940 $19.5 Million
Q3 2022 Nov 14, 2022	SELL	$20.88 - $28.21 $3.6 Million - $4.87 Million	-172,483 Reduced 20.61%	664,435 $14.3 Million
Q2 2022 Oct 27, 2022	SELL	$17.07 - $25.71 $168,105 - $253,192	-9,848 Reduced 1.16%	836,918 $16.5 Million
Q2 2022 Aug 15, 2022	SELL	$17.07 - $25.71 $168,105 - $253,192	-9,848 Reduced 1.16%	836,918 $16.5 Million
Q1 2022 Oct 27, 2022	BUY	$20.42 - $28.13 $201,096 - $277,024	9,848 Added 1.18%	846,766 $19.9 Million
Q1 2022 May 13, 2022	BUY	$20.42 - $28.13 $5.93 Million - $8.17 Million	290,597 Added 52.25%	846,766 $19.9 Million
Q4 2021 Feb 14, 2022	SELL	$25.89 - $33.45 $8.75 Million - $11.3 Million	-337,803 Reduced 37.79%	556,169 $15.2 Million
Q3 2021 Nov 15, 2021	BUY	$22.46 - $29.47 $20.1 Million - $26.3 Million	893,972 New	893,972 $24.6 Million

Others Institutions Holding INSM

# of Institutions

489

Shares Held

197M

Call Options Held

892K

Put Options Held

1.77M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $9.85B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account